BD to Spend $1.2 Billion Upgrading Manufacturing Capacity for Prefillable Syringes
By Dave Sebastian
Becton, Dickinson & Co. said Wednesday it plans to spend
about $1.2 billion expanding its manufacturing capacity for
prefillable syringes and advanced drug delivery systems over the
next four years.
The company said it will upgrade the capacity at six global
locations and add a new Europe manufacturing facility, which it
expects to start operating by the end of 2023.
"This investment positions BD to have the needed surge capacity
for increased prefillable syringe demand during times of pandemic
response or periods of significant growth of new injectable drugs
and vaccines," said Eric Borin, worldwide president of BD
Six manufacturing facilities will get a portion of the
investment include those in Columbus, Neb.; Cuautitlan, Mexico;
Fukushima, Japan; Le Pont-de-Claix, France; Swindon, U.K.; and
Write to Dave Sebastian at email@example.com
(END) Dow Jones Newswires
December 02, 2020 07:29 ET (12:29 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.